X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs STERLING BIOTECH - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON STERLING BIOTECH BIOCON /
STERLING BIOTECH
 
P/E (TTM) x 18.6 -0.4 - View Chart
P/BV x 2.9 0.0 20,571.3% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 BIOCON    STERLING BIOTECH
EQUITY SHARE DATA
    BIOCON
Mar-18
STERLING BIOTECH
Dec-13
BIOCON /
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,18811 11,314.3%   
Low Rs3053 8,970.6%   
Sales per share (Unadj.) Rs68.726.8 256.4%  
Earnings per share (Unadj.) Rs7.6-15.0 -50.5%  
Cash flow per share (Unadj.) Rs14.0-5.5 -255.7%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.10-  
Book value per share (Unadj.) Rs86.354.9 157.3%  
Shares outstanding (eoy) m600.00267.87 224.0%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.90.3 4,189.7%   
Avg P/E ratio x98.9-0.5 -21,273.7%  
P/CF ratio (eoy) x53.4-1.3 -4,200.1%  
Price / Book Value ratio x8.60.1 6,827.0%  
Dividend payout %13.20-   
Avg Mkt Cap Rs m447,9001,862 24,058.7%   
No. of employees `0006.11.4 454.1%   
Total wages/salary Rs m9,311547 1,702.8%   
Avg. sales/employee Rs Th6,705.85,303.3 126.4%   
Avg. wages/employee Rs Th1,514.2403.8 375.0%   
Avg. net profit/employee Rs Th736.9-2,959.0 -24.9%   
INCOME DATA
Net Sales Rs m41,2347,181 574.2%  
Other income Rs m2,06243 4,840.4%   
Total revenues Rs m43,2967,223 599.4%   
Gross profit Rs m8,291947 875.6%  
Depreciation Rs m3,8512,543 151.4%   
Interest Rs m6154,377 14.1%   
Profit before tax Rs m5,887-5,931 -99.3%   
Minority Interest Rs m2130-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,569-1,924 -81.5%   
Profit after tax Rs m4,531-4,007 -113.1%  
Gross profit margin %20.113.2 152.5%  
Effective tax rate %26.732.4 82.1%   
Net profit margin %11.0-55.8 -19.7%  
BALANCE SHEET DATA
Current assets Rs m41,48614,335 289.4%   
Current liabilities Rs m21,41349,809 43.0%   
Net working cap to sales %48.7-494.0 -9.9%  
Current ratio x1.90.3 673.2%  
Inventory Days Days64403 15.9%  
Debtors Days Days94171 55.2%  
Net fixed assets Rs m50,66155,432 91.4%   
Share capital Rs m3,000268 1,119.8%   
"Free" reserves Rs m48,80813,935 350.3%   
Net worth Rs m51,80814,701 352.4%   
Long term debt Rs m17,8989,478 188.8%   
Total assets Rs m99,89773,988 135.0%  
Interest coverage x10.6-0.4 -2,978.5%   
Debt to equity ratio x0.30.6 53.6%  
Sales to assets ratio x0.40.1 425.3%   
Return on assets %5.20.5 1,028.4%  
Return on equity %8.7-27.3 -32.1%  
Return on capital %9.6-6.4 -149.9%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m12,0581,860 648.3%   
Fx outflow Rs m7,34825 29,521.9%   
Net fx Rs m4,7101,835 256.7%   
CASH FLOW
From Operations Rs m6,6211,719 385.2%  
From Investments Rs m-6,840-3,148 217.3%  
From Financial Activity Rs m-2,3971,426 -168.1%  
Net Cashflow Rs m-2,612-3 76,823.5%  

Share Holding

Indian Promoters % 40.4 33.9 119.2%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 0.0 -  
FIIs % 10.7 9.9 108.1%  
ADR/GDR % 0.0 16.9 -  
Free float % 19.9 39.3 50.6%  
Shareholders   109,995 21,482 512.0%  
Pledged promoter(s) holding % 0.0 55.9 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   TTK HEALTHCARE  ALEMBIC LTD  DIVIS LABORATORIES  SANOFI INDIA  NATCO PHARMA  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End on a Strong Note; Sensex Ends 489 Points Higher(Closing)

After opening the day marginally lower, Indian share markets witnessed most of the buying interest during closing hours and ended their trading session on a strong note.

Related Views on News

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, BIOCON LTD has posted a net profit of Rs 1 bn (up 47.2% YoY). Sales on the other hand came in at Rs 11 bn (up 20.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (4QFY18); Net Profit Up 19.8% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 19.8% YoY). Sales on the other hand came in at Rs 12 bn (up 25.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Jun 20, 2019 (Close)

TRACK BIOCON

BIOCON - NOVARTIS COMPARISON

COMPARE BIOCON WITH

MARKET STATS